Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseStem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsBone Marrow TransplantationTransplantation ChimeraTissue DonorsTreatment OutcomeCord Blood Stem Cell TransplantationHematopoiesisGraft SurvivalHistocompatibility TestingMyeloablative AgonistsWhole-Body IrradiationHematopoietic Stem Cell MobilizationBusulfanHistocompatibilityAntigens, CD34LeukemiaChimerismRetrospective StudiesGraft vs Leukemia EffectLiver TransplantationRecurrenceCell DifferentiationBone Marrow CellsHematologic DiseasesMesenchymal Stem Cell TransplantationImmunosuppressive AgentsRemission InductionCombined Modality TherapyHepatic Veno-Occlusive DiseaseHLA AntigensMultiple MyelomaCell LineageSiblingsUnrelated DonorsCell TransplantationLeukemia, Myeloid, AcuteVidarabineTime FactorsMyelodysplastic SyndromesStem Cell NicheSurvival RateEmbryonic Stem CellsFlow CytometryGraft vs Tumor EffectDisease-Free SurvivalAdult Stem CellsBlood CellsTransplantation ImmunologySurvival AnalysisMelphalanMice, Inbred C57BLSevere Combined ImmunodeficiencyKidney TransplantationBone MarrowLymphocyte TransfusionFetal BloodColony-Forming Units AssayCyclophosphamideTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorSalvage TherapyCytomegalovirus InfectionsAntilymphocyte SerumAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDonor SelectionFollow-Up StudiesT-LymphocytesCells, CulturedAllograftsLymphocyte DepletionAcute DiseaseCell SeparationAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionMesenchymal Stromal CellsPluripotent Stem CellsStem Cell FactorMultipotent Stem CellsCell ProliferationImmunosuppressionOpportunistic InfectionsLymphoma, Non-HodgkinImmunocompromised HostLymphoproliferative DisordersBlood Cell CountOrgan TransplantationTransplantationPrognosisHeart Transplantation